Ophthalmologists collaborate on new blue light screen technology

Display technology provider BenQ has collaborated with blue light mitigating technology provider Eyesafe to develop a new computer monitor that reduces blue light toxicity on display systems. 

Advertisement

The monitor recycles high-energy blue light to reduce toxicity and improve performance. It was also developed in collaboration with several ophthalmologists and optometrists. 

The monitor will be debuted on Jan. 4 at the Consumer Electronics Show 2023 Innovation Showcase. 

“BenQ clearly understands the need for blue light mitigation solutions, and they are on the forefront of this important public health concern. We commend the leadership of BenQ for taking such a strong stand on blue light protection,” David Friess, OD, leader of the Eyesafe vision health advisory board, said in a Jan. 3 press release. 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Unlocking Structural Heart Capacity: How Leading Programs Use EMR and Data to Improve Patient Flow and Throughput

Wednesday, August 19
11:00 AM - 12:00 PM CDT

Presenters: Katie Kennedy, MSN, APRN, NP-C, Community Heart and VascularMisty Theriot, BSN, RN, CPHQ, FACC, Lake Charles Memorial Health SystemKatie Worthington, DNP, RN, Atlantic Health SystemTaryn Shipley, MBA, CSSBB, Lean HealthTech

Advertisement

Next Up in Ophthalmology

  • East Lansing-based Michigan Surgical Center has disclosed a data breach that may have exposed personal information, according to a July…

  • Cincinnati-based MidWest Eye Center welcomed Alec Bradley, MD, an ophthalmologist who specializes in premium cataract surgery, refractive surgery, microinvasive glaucoma…

Advertisement

Comments are closed.